Vitro Biopharma, Inc. (VTRO)
Vitro Biopharma will go public soon, but the exact IPO date is still unknown.
IPO Price Range
$5.00 - $6.00
Shares Offered
1,000,000
Deal Size
$5.50M
Vitro Biopharma Revenue
Vitro Biopharma had revenue of $3.07M in the twelve months ending April 30, 2022. In the fiscal year ending October 31, 2021, Vitro Biopharma had annual revenue of $1.31M with 102.09% growth.
Revenue (ttm)
$3.07M
Revenue Growth
+102.09%
P/S Ratio
19.78
Revenue / Employee
$169,740
Employees
12
Market Cap
40.29M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Oct 31, 2021 | 1.31M | 662.24K | 102.09% |
| Oct 31, 2020 | 648.71K | - | - |
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionVTRO News
- 1 year ago - IPO Update: Vitro Biopharma Aims For $10 Million U.S. IPO - Seeking Alpha
- 2 years ago - Vitro Biopharma IPO Registration Document (S-1) - SEC